Medications to treat opioid use disorders—new guideline from the American Society of Addiction Medicine

September 24, 2015, Wolters Kluwer Health

Medications play an important role in managing patients with opioid use disorders, but there are not enough physicians with the knowledge and ability to use these often-complex treatments. New evidence-based recommendations on the use of prescription medications for the treatment of opioid addiction are published in the October/November Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM).

Developed by an expert ASAM Guideline Committee, the National Practice Guideline provides guidance on the use of medications to treat addiction involving opioid use, according to a synopsis by Drs. Kyle Kampman of the University of Pennsylvania School of Medicine, Philadelphia, and Margaret Jarvis of Marworth Alcohol and Chemical Dependency Treatment Center, Waverly, Pa. They write, "This Practice Guideline was developed to assist in the evaluation and of opioid use, and in the hope that, using this tool, more physicians will be able to provide effective treatment."

Guidance on Using Medications for Treatment of Opioid Use Disorders

Use and misuse of opioids—morphine and related drugs, including prescription pain medications—has risen rapidly in recent years, leading the Centers for Disease Control and Prevention to declare a nationwide "opioid epidemic." Evidence supports the use of medications, in addition to psychosocial treatments, for people with opioid use disorders.

"Suboptimal treatment has likely contributed to expansion of the epidemic as well as concerns for unethical practices," Drs. Kampman and Jarvis write. "At the same time, access to competent treatment is profoundly restricted because few physicians are willing and able to provide it." The skill and time needed for effective use of medications for opioid use disorders "are not generally available to primary care doctors."

In response, ASAM assembled a multidisciplinary Guideline Committee, consisting of specialists in and other relevant fields. The guideline was developed by a formal process, combining scientific evidence and clinical knowledge. In addition to the synopsis published in the current issue of Journal of Addiction Medicine, the complete guideline can be accessed on the journal website:

The National Practice Guideline provides specific recommendations for assessment, diagnosis, and treatment, including the management of opioid withdrawal. It focuses on specific, evidence-based guidance on the major medications used in treating opioid use disorders.

Medication options include the opioid agonist (same action) medication methadone, the opioid partial agonist buprenorphine, and the opioid antagonist naltrexone. The guideline includes recommendations for appropriate use of these medications through each phase of treatment, as well as for patient monitoring and follow-up.

The guideline also addresses the rapid-acting opioid blocker naloxone, which plays a critical role in reversing . The Guideline Committee recommends that first responders such as emergency services, police officers, and firefighters be trained in and authorized to use naloxone.

The guideline also includes recommendations for patient populations with special needs and concerns: pregnant women, people with accompanying psychiatric disorders, people with pain, adolescents, and people involved in the criminal justice system. For each area addressed by the National Practice Guideline, the Committee highlights key areas for further research.

Rather than a set of hard-and-fast rules, the guideline is intended as an aid to clinical decision making for professionals at all levels of experience in treating opioid use disorders. Together with the other members of the Guideline Committee and the ASAM leadership, Drs. Kampman and Jarvis hope the information provided will help to make treatment more readily available for people with addiction involving use, thus stemming the tide of overdose deaths.

Explore further: Many opioid overdoses linked to lower prescribed doses, intermittent use

More information: "American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use." … g%20Opioid%20Use.pdf

Related Stories

Many opioid overdoses linked to lower prescribed doses, intermittent use

July 15, 2015
Overdoses of opioid pain medications frequently occur in people who aren't chronic users with high prescribed opioid doses—the groups targeted by current opioid prescribing guidelines, reports a study in the August issue ...

Education positively impacts safe opioid prescribing among clinicians

August 26, 2015
Educating clinicians on how to safely prescribe opioids can help decrease opioid misuse among chronic pain sufferers.

Emergency department opioid prescribing

May 4, 2015
The Emergency Department (ED) is at the convergence of the opioid epidemic as emergency physicians (EPs) routinely care for patients with adverse effects from opioids, including overdoses and those battling addiction, as ...

Treating infants of mothers with opioid dependence—rising rates, rising costs

May 19, 2015
As more infants are born to mothers with dependence on prescription pain medications, the costs of treatment for babies with neonatal abstinence syndrome (NAS) have increased dramatically, suggests a report in the March/April ...

Medical field urged to look within for solution to opioid addiction

September 16, 2014
University of Cincinnati (UC) researchers are asking the medical community to consider its own role in the rise in prescription opioid abuse, calling for more research on iatrogenic addiction (addiction resulting from medical ...

Recommended for you

Certain teens more likely to get hooked on opioids

March 12, 2018
(HealthDay)—Teenagers with any mental health problem are more prone to painkiller dependence after receiving a prescription opioid, a new study finds.

Prescription opioids fail rigorous new test for chronic pain

March 6, 2018
A yearlong study offers rigorous new evidence against using prescription opioids for chronic pain.

Study suggests failed osteoarthritis drug could help treat opioid addiction

February 27, 2018
A new study from Indiana University suggests that a drug proven safe for use in people may prevent opioid tolerance and physical dependence when used in combination with opioid-based pain medications.

Complex inhalers prevent patients from taking medicine

February 23, 2018
Respiratory disease patients with arthritis could struggle to manage their conditions because their inhalers are too fiddly for them to use, University of Bath research has found.

Opioid abuse leads to heroin use and a hepatitis C epidemic, researcher says

February 22, 2018
Heroin is worse than other drugs because people inject it much sooner, potentially resulting in increased risk of injection-related epidemics such as hepatitis C and HIV, a Keck School of Medicine of USC study shows.

Opioid addiction treatment behind bars reduced post-incarceration overdose deaths in RI

February 14, 2018
A treatment program for opioid addiction launched by the Rhode Island Department of Corrections was associated with a significant drop in post-incarceration drug overdose deaths and contributed to an overall drop in overdose ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.